Protara Therapeutics, Inc. (TARA)

Last Price: 14.79 (2021-04-20)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Protara Therapeutics, Inc. (TARA) had Net Income of $-33.98M for the most recently reported fiscal year, ending 2020-12-31.

Figures for fiscal year ending 2020-12-31
Income Statement Financials
--
Net Income
$-33.98M
--
--
$34.44M
$-34.44M
$0.47M
$-33.98M
$-33.98M
$-33.98M
$-33.98M
$-33.98M
$-33.98M
$-34.44M
$-34.25M
7.23M
7.23M
$-4.70
$-4.70
Balance Sheet Financials
$169.44M
$1.24M
$33.72M
$203.16M
$2.92M
--
$1.00M
$3.91M
$199.24M
$169.73M
$199.24M
11.21M
Cash Flow Statement Financials
$-23.41M
$2.83M
$189.40M
$0.56M
$169.39M
$168.83M
$9.75M
--
--
Fundamental Metrics & Ratios
58.13
--
--
--
--
--
--
--
--
--
--
$-24.29M
--
--
--
--
--
--
--
-17.05%
-20.02%
-16.73%
-17.05%
$17.77
$-3.36
$-3.24